Baraclude continues to thrive in the face of limited competition
Developed by the US based Bristol-Myers Squibb, Baraclude does not offer a paradigm change compared to Zeffix or Hepsera, the current antivira...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
